• OPEN AN ACCOUNT
Indian Indices
Sensex
76,515.43 362.57
( 0.48%)
Global Indices
Nasdaq
53,423.66 -283.45
(-0.53%)
Dow Jones
7,737.34 -31.37
(-0.40%)
Hang Seng
65,002.68 788.20
(1.23%)
Nikkei 225
10,828.70 -2.82
(-0.03%)
Forex
USD-INR
94.48 -0.24
(-0.26%)
EUR-INR
109.71 0.00
(0.00%)
GBP-INR
127.63 -0.19
(-0.15%)
JPY-INR
0.60 0.01
(1.60%)

EQUITY - MARKET SCREENER

Divis Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
532488
INE361B01024
629.4942217
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DIVISLAB
80.64
241576.41
EPS(TTM)
Face Value()
Div & Yield %
112.85
2
0.33
 

R&B Denims rises after securing Rs 216-cr denim fabric orders
Feb 23,2026
The orders are to be executed within six months as per agreed technical specifications, quality standards, and delivery schedules. The supplies are domestic in nature, and payment and other commercial terms have been mutually agreed upon between the parties.

The company stated that the order inflow strengthens revenue visibility, enhances capacity utilization, and reinforces its order book position. The promoter group has no interest in the awarding entities, and the transactions do not fall under related party transactions.

R&B Denims is engaged in the business of manufacturing and selling quality denim textile products.

The company’s consolidated net profit declined 17.9% to Rs 8.29 crore in Q3 FY26, compared with Rs 10.10 crore in Q3 FY25. However, revenue from operations rose 17.8% YoY to Rs 111.14 crore in Q3 FY26.